Senior insider sale
Chief Executive Officer at TENAYA THERAPEUTICS, INC. — senior position signals high conviction
$18.2K
14.53K shares
What this filing means
ALI FARAZ plans to sell 14.53K shares of TENAYA THERAPEUTICS, INC. valued at approximately $18.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2025ACC: 0001667937-25-000005
DirectorOfficer· Chief Executive Officer
Since Jul 2021
14.53K
Shares to sell
$18.2K
Approx. market value
39.69K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit
N/A
8/18/2025
39.69KTotal acquired39.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/18/2025 | Restricted Stock Unit N/A | 39.69K | — |
| Total | 39.69K | ||
Planned & Completed Dispositions1
Nasdaq Global SelectPlanned
Units to sell
14.53K
Market value
$18.2K
8/18/2025
Total
Units
14.53K
Value
$18.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/18/2025 | 14.53K | $18.2K | Nasdaq Global Select | Planned |
| Total | 14.53K | $18.2K | ||